Ultra-processed foods and cardiovascular risk: a new cohort
A large observational study, a real signal, and three reasons it can't prove causation on its own.
Read moreWe summarise the studies making headlines — with sample size, design, funding and limitations stated before the conclusion, not after it.
A large observational study, a real signal, and three reasons it can't prove causation on its own.
Read moreA well-powered randomised trial finds no fracture benefit in replete adults. Who might still benefit.
Read moreReformulation has done more than consumer behaviour change. The natural experiments now agree.
Read moreA hazard ratio of 0.96 is not a health revolution, whatever the headline said.
Read moreAppetite falls, but so can protein and fibre intake. What clinicians are now recommending alongside.
Read moreIncluding one we reported in 2024 — and what the newer evidence says instead.
Read moreMost misleading health news isn't invented. It's a small study described as if it were a large one.
“You're the only outlet I've seen lead with the sample size. It changed how I read everything else.”
— Jonas M., reader